
Another analyst taps the brakes
Blackbaud just got downgraded by Zacks Research from Strong Buy to Hold, which is analyst-speak for “maybe don’t sprint in here just yet.” The move matters because Blackbaud already sits on a pretty gloomy consensus — MarketBeat says the stock’s overall rating is Reduce.
The awkward mixed bag
This isn’t a clean disaster story. Blackbaud did beat quarterly EPS expectations at $1.19 versus $1.15, but revenue still fell 2.3% year over year. That’s the kind of report that makes investors squint at the spreadsheet and ask, “Okay, but is the core business actually growing?”
Guidance is doing the heavy lifting
Management’s FY2026 guidance calls for $5.150 to $5.250 in EPS, so the company is still trying to tell a steadier story on profitability. The problem is that guidance can only do so much when the top line is wobbling and analysts are turning less enthusiastic.
The other eyebrow-raiser
The article also flags about 39,801 insider shares sold over the past 90 days, worth roughly $1.89 million. Insiders don’t always have perfect timing, but when they’re selling into a soft tape, investors tend to notice. Big picture: this looks less like a dramatic collapse and more like a stock that’s losing friends one rating at a time.
